Class information for: |
Basic class information |
ID | Publications | Average number of references |
Avg. shr. active ref. in WoS |
---|---|---|---|
11863 | 884 | 37.7 | 73% |
Classes in level above (level 2) |
Terms with highest relevance score |
Rank | Term | Type of term | Relevance score (tfidf) |
Class's shr. of term's tot. occurrences |
Shr. of publ. in class containing term |
Num. of publ. in class |
---|---|---|---|---|---|---|
1 | SULODEXIDE | Author keyword | 79 | 76% | 6% | 55 |
2 | INHALED HEPARIN | Author keyword | 3 | 100% | 0% | 3 |
3 | POLYANIONIC CHARGE | Author keyword | 3 | 100% | 0% | 3 |
4 | BIOTECHNOL 4005 | Address | 2 | 50% | 0% | 3 |
5 | BREATHE WELL EXCELLENCE CHRON P DIS | Address | 1 | 38% | 0% | 3 |
6 | ANTICOAGULANT OLIGOSACCHARIDES | Author keyword | 1 | 100% | 0% | 2 |
7 | FUNCTIONAL THROMBIN RECEPTOR | Author keyword | 1 | 100% | 0% | 2 |
8 | HEPARIN LIKE DERIVATIVE | Author keyword | 1 | 100% | 0% | 2 |
9 | MED NEPHROL ENDOCRINOL 5 | Address | 1 | 50% | 0% | 2 |
10 | N DESULFATED HEPARIN | Author keyword | 1 | 50% | 0% | 2 |
Web of Science journal categories |
Author Key Words |
Key Words Plus |
Rank | Web of Science journal category | Relevance score (tfidf) |
Class's shr. of term's tot. occurrences |
Shr. of publ. in class containing term |
Num. of publ. in class |
---|---|---|---|---|---|
1 | ORAL SULODEXIDE | 44 | 88% | 2% | 21 |
2 | INHALED HEPARIN | 39 | 60% | 5% | 43 |
3 | GLYCOSAMINOGLYCAN SULODEXIDE | 30 | 84% | 2% | 16 |
4 | ANTIGEN INDUCED AIRWAY | 13 | 69% | 1% | 11 |
5 | INDUCED EOSINOPHIL INFILTRATION | 8 | 52% | 1% | 11 |
6 | TRESTATIN A | 7 | 64% | 1% | 7 |
7 | NON ANTICOAGULANT HEPARIN | 5 | 60% | 1% | 6 |
8 | SULFATE CONTENT | 5 | 55% | 1% | 6 |
9 | TERM DIABETIC RATS | 4 | 75% | 0% | 3 |
10 | HEPARIN LIKE COMPOUND | 3 | 100% | 0% | 3 |
Journals |
Reviews |
Title | Publ. year | Cit. | Active references |
% act. ref. to same field |
---|---|---|---|---|
Development and use of sulodexide in vascular diseases: implications for treatment | 2014 | 4 | 87 | 54% |
The anti-inflammatory effects of heparin and related compounds | 2008 | 85 | 95 | 34% |
Novel drug development opportunities for heparin | 2002 | 178 | 92 | 28% |
Review of pharmacodynamics, pharmacokinetics, and therapeutic properties of sulodexide | 1998 | 47 | 53 | 66% |
Sulodexide in the Treatment of Chronic Venous Disease | 2012 | 10 | 47 | 40% |
Preclinical and clinical evidence of nephro- and cardiovascular protective effects of glycosaminoglycans | 2010 | 8 | 77 | 42% |
Sulodexide: A renewed interest in this glycosaminoglycan | 2006 | 31 | 64 | 39% |
Novel therapies of diabetic nephropathy | 2009 | 34 | 40 | 23% |
The role of sulodexide in the treatment of diabetic nephropathy | 2007 | 17 | 80 | 40% |
THERAPEUTIC USES OF HEPARIN BEYOND ITS TRADITIONAL ROLE AS AN ANTICOAGULANT | 1995 | 58 | 56 | 43% |
Address terms |
Rank | Address term | Relevance score (tfidf) |
Class's shr. of term's tot. occurrences |
Shr. of publ. in class containing term |
Num. of publ. in class |
---|---|---|---|---|---|
1 | BIOTECHNOL 4005 | 2 | 50% | 0.3% | 3 |
2 | BREATHE WELL EXCELLENCE CHRON P DIS | 1 | 38% | 0.3% | 3 |
3 | MED NEPHROL ENDOCRINOL 5 | 1 | 50% | 0.2% | 2 |
4 | MEDPULM CRIT CARE UNIT | 1 | 13% | 1.1% | 10 |
5 | MED PULM CRIT CARE UNIT | 1 | 40% | 0.2% | 2 |
6 | CELL CELL MOL BIOL | 1 | 50% | 0.1% | 1 |
7 | CELLULAR SIGNALIZAT EXTRACELLULAR MATRIX | 1 | 50% | 0.1% | 1 |
8 | HAEMOSTASIS THROMBOSIS S | 1 | 50% | 0.1% | 1 |
9 | MED HAMILTON HLTH SCI | 1 | 50% | 0.1% | 1 |
10 | MEDBIOMEDICUM | 1 | 50% | 0.1% | 1 |
Related classes at same level (level 1) |
Rank | Relatedness score | Related classes |
---|---|---|
1 | 0.0000167776 | HEPARIN CONJUGATE//ORAL HEPARIN//MED UIJEONGBU ST MARYS HOSP |
2 | 0.0000164486 | CELLULAR INHIBITION//INFECT DIS INVEST SCI//PENTOSAN POLYSULPHATE SODIUM |
3 | 0.0000121803 | RGTA//DERIVATIZED DEXTRANS//HEPARAN MIMETIC |
4 | 0.0000110380 | LOCAL DRUG DELIVERY//HIRULOG LIKE PEPTIDE//ANGIOPEPTIN |
5 | 0.0000099718 | HEPARANASE//CANC VASC BIOL//PI 88 |
6 | 0.0000089668 | MUCOPOLYSACCHARIDE POLYSULFATE//CAS 530 78 9//PERFUSED PIG EAR |
7 | 0.0000080613 | SMOOTHELIN//SMTNL1//SMEMB |
8 | 0.0000080104 | DIABET CELL BIOL//CELL BIOL DIABET//LOW DENSITY LIPOPROTEIN RETENTION |
9 | 0.0000079831 | LOW MOLECULAR WEIGHT HEPARIN//UNFRACTIONATED HEPARIN//ANTI XA ACTIVITY |
10 | 0.0000077978 | SYNDECAN 1//SYNDECAN//SYNDECAN 4 |